An interventional study of Sinus self-massage and inhalation of steated boiled peppermint in Sinus Disease, sponsored by Assiut University. Not yet recruiting. Open to participants aged 65 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-08.
Sponsored by Assiut University · Not applicable, Interventional, and Treatment
Chronic rhinosinusitis (CRS) is defined as persistent symptomatic inflammation of the nasal and sinus mucosa that lasts more than 3 months. Epidemiologic studies estimate that 10% to 15% of the US population has CRS with a prevalence of up to 12% in Western populations. CRS is defined as the symptomatic inflammation of the nose and para nasals in uses with the distinction based on the duration of the complaints. CRS is typically described more broadly as an inflammatory disorder and the importance of specific microbial agents in driving the process remains controversial. It is not clear what medical therapy should be followed as the proper treatment for CRS. The most common treatment of CRS includes medical therapy and in cases resistant to medication, endoscopic sinus surgery might be an option. (Kamaneh et al., 2020).
CRS is mostly treated by antibiotics and intranasal steroids but due to limited evidence, results of treatment are unsatisfactory. Previous studies have not confirmed the efficiency of herbal medicine to treat rhinosinusitis, particularly in chronic cases. New investigations recommend that some herbal medicines, either alone or combined with other kinds of treatment might alleviate the symptoms of severe sinus infection (Pleis et al.,2010).
45 studies on the registry are indexed under Paranasal Sinus Diseases; 16 are open to participants now.
This study's planned enrollment of 108 is above the median of 80 across 28 interventional studies indexed under Paranasal Sinus Diseases.
Browse Paranasal Sinus Diseases studies →Assiut University is the lead sponsor of 5,050 studies on the registry; 2,174 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The patient should inhale steam from boiled mint leaves twice daily and perform Sinus Self-Massage to relieve nasal and sinus congestion, in addition to taking the prescribed medications.
Behavioral: Sinus self-massage and inhalation of steated boiled peppermint
routine hospital care
The patient should inhale steam from boiled mint leaves twice daily and perform Sinus Self-Massage to relieve nasal and sinus congestion, in addition to taking the prescribed medications.
rhinosinusitis-specific scale
the 22-item Sino Nasal Outcome Test (SNOT-22) will be used for measuring quality of life. Each item is categorized into 6 levels (0 for no problem to 5 for the problem is as bad as it can be). The total score is gained by adding the score of each item (range 0-110) with lower scores implying a better health-related quality of life. It covers a wide range of health-related quality of life that may affect patient outcomes. SNOT subscales include 5 questions on rhinological symptoms, 4 questions on ear/facial symptoms, 3 questions on sleep function and 6 questions on psychological function. As with the total SNOT scale, higher scores indicate worse symptoms and lower quality of life
Time frame: 3 months
Visual Analog Pain Scale
It was adopted from Chiarotto et al. (2019) and used by the researcher to assess the severity of low back pain. Scoring system: The total scores of the visual analog pain scale ranged from (0-10);
Time frame: 3 months
No study locations are listed for this record.
Plan to share: Yes
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Dec 2027, 14 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.